140648-72-2

Upstream product

• 56624-93-2 ethoxycarbonyl-2 methyl-2 dioxolanne-1,3 
• 61999-49-3 1-(4-methoxyphenyl)-4-methyl-2-azetidinone 

Downstream Products

• 140648-94-8 (3R,4S)-3-[(R)-Hydroxy-(2-methyl-[1,3]dioxolan-2-yl)-methyl]-1-(4-methoxy-phenyl)-4-methyl-azetidin-2-one 
• 111390-89-7 (E)-4-methyl-3-(2-oxopropylidene)azetidin-2-one 
• 140649-16-7 Methanesulfonic acid (S)-[(2R,3S)-1-(4-methoxy-phenyl)-2-methyl-4-oxo-azetidin-3-yl]-(2-methyl-[1,3]dioxolan-2-yl)-methyl ester 
• 111390-68-2 1-(4-Methoxy-phenyl)-4-methyl-3-[2-oxo-prop-(Z)-ylidene]-azetidin-2-one 
• 111390-67-1 1-(4-Methoxy-phenyl)-4-methyl-3-[2-oxo-prop-(E)-ylidene]-azetidin-2-one 
• 140649-63-4 1-(4-Methoxy-phenyl)-4-methyl-3-[1-(2-methyl-[1,3]dioxolan-2-yl)-meth-(Z)-ylidene]-azetidin-2-one 
• 140649-40-7 1-(4-Methoxy-phenyl)-4-methyl-3-[1-(2-methyl-[1,3]dioxolan-2-yl)-meth-(E)-ylidene]-azetidin-2-one 

Relevant academic research and scientific papers

Synthesis and platelet aggregation inhibitory activities of 3-(2-oxopropylidene)azetidin-2-one derivatives. II

A series of 3-acylidene-4-methylazetidin-2-one derivatives bearing various substituents at the 1-position of the azetidin-2-one ring was synthesized. These compounds were evaluated for platelet aggregation inhibitory activities. Most of the compounds synt